UTA Examines Antimalarial Drugs to Treat COVID-19
July 30, 2020
July 30, 2020
ARLINGTON, Texas, July 30 -- The University of Texas Arlington campus issued the following news release:
A published study from researchers at The University of Texas at Arlington suggests that using chloroquine and hydroxychloroquine on COVID-19 (SARS-Cov-2) patients can have dangerous side effects, especially for older adults.
The benefits of the drugs, say the authors, are "at best, hypothetical."
The study appears in the journal Revista de Sau . . .
A published study from researchers at The University of Texas at Arlington suggests that using chloroquine and hydroxychloroquine on COVID-19 (SARS-Cov-2) patients can have dangerous side effects, especially for older adults.
The benefits of the drugs, say the authors, are "at best, hypothetical."
The study appears in the journal Revista de Sau . . .